Zymeworks Net Worth 2016-2022 | ZYME

Interactive chart of historical net worth (market cap) for Zymeworks (ZYME) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Zymeworks net worth as of March 30, 2023 is $0.52B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.517B $0.412B
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.445B 8.86
GSK (GSK) United Kingdom $75.664B 9.49
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.416B 19.30
Ginkgo Bioworks Holdings (DNA) United States $2.487B 0.00
Arcus Biosciences (RCUS) United States $1.286B 0.00
Biohaven (BHVN) United States $0.930B 0.00
Emergent Biosolutions (EBS) United States $0.446B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.149B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00
Gelesis Holdings (GLS) United States $0.014B 0.00